NASDAQ:HSCSW Heart Test Laboratories (HSCSW) Stock Price, News & Analysis → Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (From Banyan Hill Publishing) (Ad) Free HSCSW Stock Alerts $0.04 0.00 (0.00%) (As of 04/23/2024 ET) Add Compare Share Share Today's Range$0.04▼$0.0450-Day Range$0.02▼$0.0952-Week Range$0.01▼$0.45VolumeN/AAverage Volume2,919 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Get Heart Test Laboratories alerts: Email Address Ad Banyan Hill PublishingDon’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him About Heart Test Laboratories Stock (NASDAQ:HSCSW)Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.Read More HSCSW Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HSCSW Stock News HeadlinesApril 7, 2024 | msn.comNew approach to diagnosing heart disease hailed as potential ‘game changer’March 16, 2024 | finance.yahoo.comHeart Test Laboratories Third Quarter 2024 Earnings: US$0.031 loss per share (vs US$0.16 loss in 3Q 2023)April 23, 2024 | Banyan Hill Publishing (Ad)Don’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.March 14, 2024 | investorplace.comHSCS Stock Earnings: Heart Test Laboratories Beats EPS for Q3 2024February 6, 2024 | msn.comHeart-on-a-chip: A microfluidic marvel shaping the future of cardiovascular researchFebruary 1, 2024 | finance.yahoo.comHeartSciences Appoints New Scientific Advisory Board MemberFebruary 1, 2024 | bizjournals.comGreater Houston heart and vascular program tackles AFib with cutting-edge treatmentsJanuary 18, 2024 | finance.yahoo.comHeartSciences Announces Results and Adjournment of Annual Shareholder MeetingApril 23, 2024 | Banyan Hill Publishing (Ad)Don’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.January 3, 2024 | finance.yahoo.comHeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder MeetingDecember 14, 2023 | finance.yahoo.comHeartSciences Reports Second Quarter Fiscal 2024 Financial ResultsDecember 5, 2023 | msn.comHeart Test stock rallies 27% on FDA update for MyoVista submissionDecember 5, 2023 | finance.yahoo.comHeartSciences Receives FDA Confirmation for 510(k) Clearance PathwayNovember 29, 2023 | benzinga.comHeart Test Laboratories Stock (NASDAQ:HSCS) Dividends: History, Yield and DatesNovember 15, 2023 | markets.businessinsider.comWhy Is Heart Test Laboratories (HSCS) Stock Up 43% Today?November 13, 2023 | finance.yahoo.comHeartSciences’ MyoVista® wavECGTM Selected for Heart Screening of Irish Garda National Police OfficersNovember 8, 2023 | investorplace.comWhy Is Heart Test Laboratories (HSCS) Stock Up 298% Today?September 26, 2023 | finance.yahoo.comHeartSciences Receives Two New Patent Allowances, Expanding its International Patent PortfolioSeptember 15, 2023 | finanznachrichten.deHeart Test Laboratories, Inc.: HeartSciences Reports First Quarter Fiscal 2024 Financial ResultsSeptember 12, 2023 | finance.yahoo.comHeartSciences to Present at the Gilmartin Group Emerging Growth ShowcaseSeptember 7, 2023 | finance.yahoo.comHeartSciences Signs Distribution Agreement with MedPhy Technologies, Mumbai, IndiaAugust 31, 2023 | news.yahoo.comStudy finds half of cardiac patients have these ‘tell tale symptoms’ day before heart attackJuly 27, 2023 | finance.yahoo.comMyoVista wavECG goes into clinical use at the Naya Imaging Center in DenmarkJuly 23, 2023 | dailymail.co.ukThe heart attack testJuly 7, 2023 | msn.comPotentially Life Saving Cardiac Lab Opens At Plainview HospitalMay 9, 2023 | finance.yahoo.comHeartSciences Announces Completion of Patient Enrollment for FDA Pivotal Study of MyoVista wavECGMay 2, 2023 | finance.yahoo.comHeartSciences to Participate in The Benchmark Company’s Virtual Individual Investor Healthcare ConferenceSee More Headlines Receive HSCSW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Heart Test Laboratories and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolNASDAQ:HSCSW CUSIPN/A CIK1468492 Webheartsciences.com Phone682-237-7781FaxN/AEmployees12Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$18,600.00 Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Andrew Simpson (Age 54)CEO, President & Chairman of the Board of Directors Comp: $264.14kMs. Danielle Watson (Age 41)CFO & Treasurer Comp: $188.75kMr. Mark T. Hilz (Age 65)COO, Secretary & Director Comp: $263.61kKey CompetitorsAinosNASDAQ:AIMDWBone BiologicsNASDAQ:BBLGWDIH Holding USNASDAQ:DHAIWEnvoy MedicalNASDAQ:COCHWInspira Technologies Oxy B.H.N.NASDAQ:IINNWView All Competitors HSCSW Stock Analysis - Frequently Asked Questions How have HSCSW shares performed in 2024? Heart Test Laboratories' stock was trading at $0.05 at the beginning of 2024. Since then, HSCSW shares have decreased by 28.8% and is now trading at $0.0356. View the best growth stocks for 2024 here. How do I buy shares of Heart Test Laboratories? Shares of HSCSW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:HSCSW) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”AltimetryEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heart Test Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
